VALN — Valneva SE
—
Nasdaq ·
Health Care ·
Biotechnology ·
CIK 1836564 ·
Last close
$4.97
Market Cap
$507.53M
52W High
$6.73
52W Low
$4.75
ADV30
23,860
Next earnings
—
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Mar 2026 | 30,903,000 | 4,723,000 | -23,696,000 | -32,073,000 | 372,013,000 | 105,265,000 | 295,314,000 |
| Dec 2025 | 47,687,000 | 11,616,000 | -27,685,000 | -50,019,000 | 398,836,000 | 109,650,000 | 292,668,000 |
| Sep 2025 | 29,409,000 | 5,503,000 | -37,347,000 | -44,355,000 | 448,229,000 | 143,462,000 | 297,752,000 |
| Jun 2025 | 48,330,000 | 24,211,000 | -10,638,000 | -11,586,000 | 472,625,000 | 161,307,000 | 286,193,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-52,895,000
Investing CF
$-1,709,000
Financing CF
$-622,000
CapEx
$-4,481,000
Dividends Paid
$0
Buybacks
—
EPS Diluted TTM
$-0.12
As of
2026-05-10
Balance + Analyst (yfinance extras)
Retained Earnings
$-679,120,000
Inventory
$50,232,000
Receivables
$27,813,000
ST Investments
—
EBIT TTM
$-72,221,000
Pretax Income TTM
$-114,119,000
Interest Exp TTM
$41,898,000
Analysts
4
Yahoo Snapshot (yfinance, live)
Total Revenue
$156,331,008
EBITDA
$-81,880,496
Free Cash Flow
$-31,007,750
Enterprise Value
$547,025,600
Total Cash
$105,265,000
Total Debt
$209,504,992
Shares Out
102,119,642
Trailing EPS
$-1.83
Book Value
$0.98
ROE
-109.6%
ROA
-14.5%
Div Yield
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 174,658,000 | -81,631,000 | -115,192,000 | 398,836,000 | 292,668,000 | — | -52,894,000 |
| Dec 2024 | 169,578,000 | -77,769,000 | -12,247,000 | 500,032,000 | 318,779,000 | — | -67,218,000 |
| Dec 2023 | 153,712,000 | -82,112,000 | -101,429,000 | 460,062,000 | 331,815,000 | — | -202,744,000 |
| Dec 2022 | 361,303,000 | -113,443,000 | -143,279,000 | 621,344,000 | 401,547,000 | — | -245,343,000 |
TTM Snapshot
Revenues TTM
—
NetIncome TTM
—
OpCashFlow TTM
—
Assets (Latest)
—
Forward EPS
$1.04
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| ZURA | Zura Bio Ltd | $515.20M | $5.43 | — |
| EIKN | Eikon Therapeutics, Inc. | $498.62M | $9.21 | — |
| ARTV | Artiva Biotherapeutics, Inc. | $490.74M | $10.10 | — |
| PRME | Prime Medicine, Inc. | $527.40M | $2.92 | — |
| TECX | Tectonic Therapeutic, Inc. | $528.90M | $28.03 | — |
News headlines (Yahoo Finance, 1h cache)
Valneva to Report First Half 2026 Consolidated Financial Results on August 13, 2026
2026-07-22 15:45 · Yahoo
Declaration voting rights - June 30,2026
2026-07-02 16:00 · Yahoo
Valneva Announces Successful Outcome of its Annual General Meeting
2026-06-25 15:45 · Yahoo
Valneva Announces Availability of Documentation for its Annual General Meeting
2026-06-04 05:00 · Yahoo
VALNEVA:Declaration of shares and voting rights - Status as of May 31, 2026
2026-06-03 16:00 · Yahoo
Valneva to Participate at U.S. and European Investor Conferences in June
2026-05-28 15:45 · Yahoo
Valneva SE (INRLF) Q1 2026 Earnings Call Highlights: Promising Vaccine Developments Amid ...
2026-05-13 23:00 · Yahoo
Valneva Q1 Earnings Call Highlights
2026-05-13 19:10 · Yahoo
Transcript: Valneva Q1 2026 Earnings Conference Call
2026-05-13 15:51 · Yahoo
Valneva Reports First Quarter 2026 Financial Results and Provides Corporate Updates
2026-05-13 05:00 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.